GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE

Dettagli Bibliografici
Autori principali:	Wilcock, G, Scott, M, Pearsall, T, Neubauer, K, Boyle, M, Razay, G
Natura:	Journal article
Pubblicazione:	1993

Documenti analoghi

Galantamine in Alzheimer's disease.
di: Razay, G, et al.
Pubblicazione: (2008)

Hyperinsulinaemia and Alzheimer's disease.
di: Razay, G, et al.
Pubblicazione: (1994)

Synthesis of galanthamine
di: Laszlo Czollner, et al.
Pubblicazione: (2001-11-01)

The metabolic syndrome and Alzheimer disease.
di: Razay, G, et al.
Pubblicazione: (2007)

Obesity, abdominal obesity and Alzheimer disease.
di: Razay, G, et al.
Pubblicazione: (2006)

Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type
di: Wilcock, G, et al.
Pubblicazione: (1997)

Insulin resistance, dyslipidemia and the risk of Alzheimer's disease: A case-control study
di: Razay, G, et al.
Pubblicazione: (2011)

Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
di: Razay, G, et al.
Pubblicazione: (2009)

Integrating Narcissus-derived galanthamine production into traditional upland farming systems
di: M. D. Fraser, et al.
Pubblicazione: (2021-01-01)

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
di: Wilcock, G, et al.
Pubblicazione: (1993)

Synthesis of Precursors for the Oxidative Tandem Cyclization of Diphenols to Galanthamine Analogs
di: Ulrich Jordis, et al.
Pubblicazione: (2002-01-01)

Cloning and characterization of a norbelladine 4'-O-methyltransferase involved in the biosynthesis of the Alzheimer's drug galanthamine in Narcissus sp. aff. pseudonarcissus.
di: Matthew B Kilgore, et al.
Pubblicazione: (2014-01-01)

Treatment for Alzheimer's disease.
di: Wilcock, G
Pubblicazione: (2000)

Cloning and characterization of a tyrosine decarboxylase involved in the biosynthesis of galanthamine in Lycoris aurea
di: Rong Wang, et al.
Pubblicazione: (2019-04-01)

Analysis on the thermal decomposition kinetics and storage period of biomass-based lycorine galanthamine
di: Chong Qin, et al.
Pubblicazione: (2023-04-01)

Current approaches to the treatment of Alzheimer's disease.
di: Wilcock, G
Pubblicazione: (1996)

Treatment of the cholinergic impairment in Alzheimer's disease
di: Wilcock, G
Pubblicazione: (1994)

Characterization of norbelladine synthase and noroxomaritidine/norcraugsodine reductase reveals a novel catalytic route for the biosynthesis of Amaryllidaceae alkaloids including the Alzheimer’s drug galanthamine
di: Bharat Bhusan Majhi, et al.
Pubblicazione: (2023-08-01)

Lipase-catalysed synthesis of a novel galanthamine derivative: process optimisation by artificial neural networks
di: Ashari, Siti Efliza, et al.
Pubblicazione: (2020)

Wild Argentinian Amaryllidaceae, a New Renewable Source of the Acetylcholinesterase Inhibitor Galanthamine and Other Alkaloids
di: Gabriela E. Feresin, et al.
Pubblicazione: (2012-11-01)

Treatment of Alzheimer's disease: future directions.
di: Wilcock, G, et al.
Pubblicazione: (1996)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
di: Wilcock, G
Pubblicazione: (2007)

Long-term use of tacrine
di: Wilcock, G, et al.
Pubblicazione: (1994)

Long-term use of tacrine.
di: Wilcock, G, et al.
Pubblicazione: (1994)

Drug treatment of Alzheimer's disease - a clinician's view point
di: Wilcock, G
Pubblicazione: (1991)

Dynamics of Growth and Galanthamine Biosynthesis in <i>Hippeastrum papilio</i> (Ravena) Van Sheepen Hydroponic Culture
di: Gabriela Haist, et al.
Pubblicazione: (2024-09-01)

Transcriptomic and Metabolomic Analyses Reveals That Exogenous Methyl Jasmonate Regulates Galanthamine Biosynthesis in Lycoris longituba Seedlings
di: Qingzhu Li, et al.
Pubblicazione: (2021-09-01)

Age and Alzheimer's disease.
di: Wilcock, G, et al.
Pubblicazione: (1983)

Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.
di: Wilcock, G
Pubblicazione: (2006)

Neurotrophins in Alzheimer's disease
di: Wilcock, G
Pubblicazione: (2002)

Asymmetry of pathology in Alzheimer's disease.
di: Wilcock, G, et al.
Pubblicazione: (1987)

The olfactory bulbs in Alzheimer's disease.
di: Esiri, M, et al.
Pubblicazione: (1984)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
di: Wilcock, G
Pubblicazione: (1990)

Alzheimer's disease--current issues.
di: Wilcock, G
Pubblicazione: (1988)

The increasing burden of Alzheimer disease.
di: Sadik, K, et al.
Pubblicazione: (2003)

The effects of galantamine treatment on caregiver time in Alzheimer's disease.
di: Sano, M, et al.
Pubblicazione: (2003)

Treating Alzheimer's disease.
di: Wilcock, G, et al.
Pubblicazione: (1995)

Velnacrine for Alzheimer's disease.
di: Birks, J, et al.
Pubblicazione: (2004)

Bapineuzumab in Alzheimer's disease: where now?
di: Wilcock, G
Pubblicazione: (2010)

Endophytic bacteria from in vitro culture of Leucojum aestivum L. a new source of galanthamine and elicitor of alkaloid biosynthesis
di: Agata Ptak, et al.
Pubblicazione: (2022-08-01)